Advertisement

Labeled Antibodies in the Localization and Therapy of Thyroid Carcinoma

  • Shigenobu Nagataki

Abstract

Radioimmunodetection, or radioimmunoimaging, detects tumors by using labeled antibodies against tumor-specific or tumor-associated antigens. This technique has been employed widely to detect carcinoembryonic antigen (1,2), alpha feto protein (3), and chorionic gonadotropin-producing tumors (4). Application of specific monoclonal antibodies has also been investigated (5–7).

Keywords

Nude Mouse Thyroid Tissue Thyroid Cell Follicular Adenoma Alpha Feto Protein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Goldenberg DM, Kim EE, DeLand FH, et al. Cancer Res 40: 2984, 1980.PubMedGoogle Scholar
  2. 2.
    Mach JP, Forni M, Ritschard J, et al. Oncodev Biol Med 1: 49, 1980.PubMedGoogle Scholar
  3. 3.
    Ishii N, Nakata K, Muro T, et al. Ann NY Acad Sci 417: 270, 1983.PubMedCrossRefGoogle Scholar
  4. 4.
    Goldenberg DM, Kim EE, and DeLand FH. Proc Natl Acad Sci 78: 7754, 1981.PubMedCrossRefGoogle Scholar
  5. 5.
    Mach JP, Buchegger F, Forni M, et al. Immunology Today 2: 239, 1981.CrossRefGoogle Scholar
  6. 6.
    Farrands PA, Perkins AC, Pimm MV, et al. Lancet II 8295: 397, 1982.CrossRefGoogle Scholar
  7. 7.
    Ishii N, Munehisa T, Koji T, et al. In H Peeters (ed), Protides of the Biological Fluids, Volume 31, Pergamon Press, Oxford and New York, 1984, p 305.Google Scholar
  8. 8.
    Inoue K, Horiuchi R, and Kondo Y. Endocrinology 107: 1162, 1980.PubMedCrossRefGoogle Scholar
  9. 9.
    Kawaoi A. An Illustrated Technology of Immunofluorescence: Its Principles, Practice and Applications, Soft Science, Inc., Tokyo, 1983, p 7.Google Scholar
  10. 10.
    Mckay IC, Forman D, and White RG. Immunology 43: 591, 1981.PubMedGoogle Scholar
  11. 11.
    Nitsch L and Wollman SH. J Cell Biol 86: 875, 1980.PubMedCrossRefGoogle Scholar
  12. 12.
    Hanafusa T, Pujol-Bomell R, Chiovato L, et al. Clin Exp Immunol 58: 639, 1984.Google Scholar
  13. 13.
    Khoury EL, Bottazzo GF, and Roitti LM. J Exp Med 159: 577, 1984.PubMedCrossRefGoogle Scholar
  14. 14.
    Davies TF, Platzer M, Schwartz AE, et al. Clin Endocrinol 21: 239, 1984.CrossRefGoogle Scholar
  15. 15.
    Chambard M, Gabrion J, and Mauchamp J. J Cell Biol 91: 157, 1981.PubMedCrossRefGoogle Scholar
  16. 16.
    Hirayu H, Izumi M, Morita S, et al. Oncodevel Biol Med 4: 63, 1983.Google Scholar
  17. 17.
    Fairweather DS, Bradwell AR, Watson-James SF, et al. Clin Endocrinol 18: 563, 1983.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1986

Authors and Affiliations

  • Shigenobu Nagataki
    • 1
  1. 1.The First Department of Internal MedicineNagasaki University School of MedicineNagasakiJapan

Personalised recommendations